Confirming the usefulness of biomarkers of interest and measuring biomarkers in patient samples. **Learn more about the biomarker lab below or advance to the next page to move on to the central lab**
PPD Laboratories takes a collaborative cross-functional approach to each project in order to provide the flexibility needed to develop customized solutions. Our dedicated biomarker laboratories across the globe work closely with customers to shape biomarker strategy and drive projects to completion even where uncertainty exists.
Biomarkers reveal critical insights about your drug and its potential for commercial success, our biomarker lab has supported more than 750 programs in the past five years. Our capabilities include:
We are committed to helping customers identify the right strategy for each development phase so they can efficiently achieve their end goals Our approach:
Our biomarker lab developed a sophisticated new method to precisely monitor the persistence of CAR T-cells in a Phase I study. In collaboration with the customer, we adapted a flow cytometry assay with a novel internal control to accurately quantify the engineered cells. Well-controlled studies validated that the new flow cytometry assay was both suitable and repeatable.
Take a tour of our molecular genomics suite >
